US court may bunch cases against GSK, aid Ranbaxy
Ranbaxy Laborities said it expects a US court to combine its patent case against GlaxoSmithKline (GSK) Plc over blockbuster antibiotic Augmentin with those of two companies which won legal victories
Ranbaxy Laborities said it expects a US court to combine its patent case against GlaxoSmithKline (GSK) Plc over blockbuster antibiotic Augmentin with those of two companies which won legal victories